Build on the foundational knowledge established with the Ausmed Course, Central Venous Access Devices, with this deep-dive exploration of the common complications associated with central venous access devices (CVADs) and the best-practice nursing interventions for prevention and management.
Identify and describe the common complications associated with central venous access devices (CVADs).
Demonstrate knowledge of the strategies and functions of using best-practice assessments in maintaining CVAD patency.
Understand the principles of infection prevention and control and apply evidence-based practices for the prevention and management of CVAD-associated infections.
Recognise best-practice assessment and management of common skin complications related to CVADs.
Apply appropriate teaching strategies to address individual patient needs, and promote patient adherence and active participation in the management of their CVAD.
Nurses and other healthcare professionals looking to deepen their knowledge of complications that commonly occur with CVADs.
Central venous access devices (CVADs) are highly prevalent within inpatient and community healthcare settings across all populations and pose a high risk for complications to arise. Between 15–66% of CVADs may fail prematurely as a result of complications.
It is therefore crucial that healthcare professionals caring for patients with these devices have an in-depth and up-to-date understanding of the various kinds of complications that can occur, prevention strategies, and how to manage treatment in partnership with patients in order to maintain safety and achieve optimal outcomes.
The purpose of this Ausmed Course is to provide learners with an in-depth understanding of the various kinds of complications that commonly occur for patients with CVADs and best practices for prevention, treatment and management strategies.
Assign mandatory training and keep all your records in-one-place.
Find out more
Ausmed Education is a Trusted Information Partner of Healthdirect Australia. Verify here.
New 
